← All organizations
Highest phase reached
Phase 2
First clinical trial
May 31, 2020Last known activity
May 31, 2020
Timeline
2010s
- Jan 3, 2019
Tiburio Therapeutics— Founded
Drugs by trial phase (1 distinct, 1 trials)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (1)
- NCT04335357Lead sponsorPhase 2May 31, 2020
Details
- Founded
- Cambridge, MA, US Jan 3, 2019
- Last known activity
- May 31, 2020